UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 316

Sortiert nach

Radotinib inhibits multiple myeloma cell proliferation via suppression of STAT3 signaling

PloS one, 2022-05, Vol.17 (5), p.e0265958-e0265958

2022

Volltextzugriff (PDF)

Development of a new clinical index to easily assess frailty of elderly patients with multiple myeloma in Asian population

Scientific reports, 2021-11, Vol.11 (1), p.22907-22907, Article 22907

2021

Volltextzugriff (PDF)

LIGHT (TNFSF14) promotes the differentiation of human bone marrow-derived mesenchymal stem cells into functional hepatocyte-like cells

PloS one, 2023-08, Vol.18 (8), p.e0289798-e0289798

2023

Volltextzugriff (PDF)

Risk factors of menopause after allogeneic hematopoietic cell transplantation in premenopausal adult women

European journal of haematology, 2023-09, Vol.111 (3), p.449-457

2023

Volltextzugriff (PDF)

Multicenter phase III trial of S-1 and cisplatin versus S-1 and oxaliplatin combination chemotherapy for first-line treatment of advanced gastric cancer (SOPP trial)

Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association, 2021, Vol.24 (1), p.156-167

2021

Volltextzugriff (PDF)

The soluble VCAM-1 level is a potential biomarker predicting severe acute graft versus host disease after allogeneic hematopoietic cell transplantation

BMC cancer, 2022-09, Vol.22 (1), p.1-997, Article 997

2022

Volltextzugriff (PDF)

Late complications and quality of life assessment for survivors receiving allogeneic hematopoietic stem cell transplantation

Supportive care in cancer, 2021-02, Vol.29 (2), p.975-986

2021

Volltextzugriff (PDF)

LIGHT (TNFSF14) enhances osteogenesis of human bone marrow-derived mesenchymal stem cells

PloS one, 2021-02, Vol.16 (2), p.e0247368-e0247368

2021

Volltextzugriff (PDF)

Radotinib enhances cytarabine (Ara-C)-induced acute myeloid leukemia cell death

BMC cancer, 2020-12, Vol.20 (1), p.1193-15, Article 1193

2020

Volltextzugriff (PDF)

Plasmacytoid dendritic cell neoplasms

Blood Research, 2023, 58(0), , pp.90-95

2023

Volltextzugriff (PDF)

LIGHT (TNFSF14) Increases the Survival and Proliferation of Human Bone Marrow-Derived Mesenchymal Stem Cells

PloS one, 2016-11, Vol.11 (11), p.e0166589-e0166589

2016

Volltextzugriff (PDF)

Targeting c-KIT (CD117) by dasatinib and radotinib promotes acute myeloid leukemia cell death

Scientific reports, 2017-11, Vol.7 (1), p.15278-12, Article 15278

2017

Volltextzugriff (PDF)

Multicenter retrospective analysis of the clinicopathologic features of monomorphic epitheliotropic intestinal T-cell lymphoma

Annals of hematology, 2019-11, Vol.98 (11), p.2541-2550

2019

Volltextzugriff (PDF)

Mobilization of hematopoietic stem cells with lenograstim in multiple myeloma patients: Prospective multicenter observational study (KMM122)

Cancer medicine (Malden, MA), 2023-04, Vol.12 (8), p.9186-9193

2023

Volltextzugriff (PDF)

The effects of erythropoiesis‐stimulating agents on the management of chemotherapy‐induced anemia and tumor growth in diffuse large B‐cell lymphoma patients

International journal of cancer, 2019-11, Vol.145 (9), p.2459-2467

2019

Volltextzugriff (PDF)

Poor prognostic impact of high serum ferritin levels in patients with a lower risk of diffuse large B cell lymphoma

International journal of hematology, 2020-04, Vol.111 (4), p.559-566

2020

Volltextzugriff (PDF)

The c-Abl inhibitor, radotinib induces apoptosis in multiple myeloma cells via mitochondrial-dependent pathway

Scientific reports, 2021-06, Vol.11 (1), p.13198-13198, Article 13198

2021

Volltextzugriff (PDF)

Real-world toxicity and effectiveness of ixazomib, lenalidomide, and dexamethasone in Korean patients with relapsed and/or refractory multiple myeloma

International journal of hematology, 2023-02, Vol.117 (2), p.225-235

2023

Volltextzugriff (PDF)

Monosomal karyotype affecting outcomes of allogeneic hematopoietic stem cell transplantation for acute myeloid leukemia in first complete remission

European journal of haematology, 2020-09, Vol.105 (3), p.262-273

2020

Volltextzugriff (PDF)

Pegteograstim prophylaxis for chemotherapy-induced neutropenia and febrile neutropenia: a prospective, observational, postmarketing surveillance study in Korea

Supportive care in cancer, 2021-09, Vol.29 (9), p.5383-5390

2021

Volltextzugriff (PDF)

Clinicopathologic Characteristics Associated with Prognosis in Ocular Extranodal Marginal Zone B Cell Lymphoma

Medicina (Kaunas, Lithuania), 2022-06, Vol.58 (6), p.818

2022

Volltextzugriff (PDF)

Changes in decision-making process for life-sustaining treatment in patients with advanced cancer after the life-sustaining treatment decisions-making act

BMC palliative care, 2021-04, Vol.20 (1), p.63-63, Article 63

2021

Volltextzugriff (PDF)

Dasatinib accelerates valproic acid-induced acute myeloid leukemia cell death by regulation of differentiation capacity

PloS one, 2014-06, Vol.9 (2), p.e98859

2014

Volltextzugriff (PDF)

Radotinib Induces Apoptosis of CD11b+ Cells Differentiated from Acute Myeloid Leukemia Cells

PloS one, 2015-06, Vol.10 (6), p.e0129853-e0129853

2015

Volltextzugriff (PDF)

PB2298: CHRONIC HEPATITIS B VIRAL ACTIVITY IS AN INDEPENDENT PROGNOSTIC FACTOR OF LYMPHOMA

HemaSphere, 2023-08, Vol.7 (S3), p.e06674b3-n/a

2023

Volltextzugriff (PDF)

1 – 25 von 316

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(286)
Mit Volltextzugriff
(308)

Publikationsform

Sprache

Englisch
(280)
Koreanisch
(36)
Japanisch
(16)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Radotinib inhibits multiple myeloma cell proliferation via suppression of STAT3 signaling

Development of a new clinical index to easily assess frailty of elderly patients with multiple myeloma in Asian population

LIGHT (TNFSF14) promotes the differentiation of human bone marrow-derived mesenchymal stem cells into functional hepatocyte-like cells

Risk factors of menopause after allogeneic hematopoietic cell transplantation in premenopausal adult women

Multicenter phase III trial of S-1 and cisplatin versus S-1 and oxaliplatin combination chemotherapy for first-line treatment of advanced gastric cancer (SOPP trial)

The soluble VCAM-1 level is a potential biomarker predicting severe acute graft versus host disease after allogeneic hematopoietic cell transplantation

Late complications and quality of life assessment for survivors receiving allogeneic hematopoietic stem cell transplantation

LIGHT (TNFSF14) enhances osteogenesis of human bone marrow-derived mesenchymal stem cells

Radotinib enhances cytarabine (Ara-C)-induced acute myeloid leukemia cell death

Plasmacytoid dendritic cell neoplasms

LIGHT (TNFSF14) Increases the Survival and Proliferation of Human Bone Marrow-Derived Mesenchymal Stem Cells

Targeting c-KIT (CD117) by dasatinib and radotinib promotes acute myeloid leukemia cell death

Multicenter retrospective analysis of the clinicopathologic features of monomorphic epitheliotropic intestinal T-cell lymphoma

Mobilization of hematopoietic stem cells with lenograstim in multiple myeloma patients: Prospective multicenter observational study (KMM122)

The effects of erythropoiesis‐stimulating agents on the management of chemotherapy‐induced anemia and tumor growth in diffuse large B‐cell lymphoma patients

Poor prognostic impact of high serum ferritin levels in patients with a lower risk of diffuse large B cell lymphoma

The c-Abl inhibitor, radotinib induces apoptosis in multiple myeloma cells via mitochondrial-dependent pathway

Real-world toxicity and effectiveness of ixazomib, lenalidomide, and dexamethasone in Korean patients with relapsed and/or refractory multiple myeloma

Monosomal karyotype affecting outcomes of allogeneic hematopoietic stem cell transplantation for acute myeloid leukemia in first complete remission

Pegteograstim prophylaxis for chemotherapy-induced neutropenia and febrile neutropenia: a prospective, observational, postmarketing surveillance study in Korea

Clinicopathologic Characteristics Associated with Prognosis in Ocular Extranodal Marginal Zone B Cell Lymphoma

Changes in decision-making process for life-sustaining treatment in patients with advanced cancer after the life-sustaining treatment decisions-making act

Dasatinib accelerates valproic acid-induced acute myeloid leukemia cell death by regulation of differentiation capacity

Radotinib Induces Apoptosis of CD11b+ Cells Differentiated from Acute Myeloid Leukemia Cells

PB2298: CHRONIC HEPATITIS B VIRAL ACTIVITY IS AN INDEPENDENT PROGNOSTIC FACTOR OF LYMPHOMA

Suchergebnisse filtern